Healthtech startup RxALL raises US$3.15 million to scale up anticounterfeit technology

NIGERIA – RxAll, a health startup company based in the USA and in Nigeria, has announced a financing round of US$3.15 million to scale operations across existing markets and improve its drug checking and counterfeiting technology. This funding round combines a recently closed US$2 million seed round (which was oversubscribed by US$2.25 million) and a US$900,000 pre-seed round raised at the end of last year. The startup, founded in 2016 by Adebayo Alonge, Amy Kao and Wei Lui, has deployed deep technology to provide quality medication to patients in a…

Read More